2017•Forensic Science InternationalOpen access

Zopiclone concentrations in oral fluid and blood after, administration of therapeutic doses of zopiclone

Knut Hjelmeland, Ingebjørg Gustavsen, Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Gudrun Høiseth, Jørg Gustav Mørland

Open full text 7 citations

Abstract

Purpose Little is known about the relationship between concentrations in oral fluid (OF) and blood for the widely prescribed hypnotic drug zopiclone . The purpose of this study was to investigate the usefulness of OF zopiclone concentrations to predict blood zopiclone concentrations in order to introduce OF testing as an alternative to more cumbersome blood testing. Methods 16 healthy young male volunteers received capsules of either 5 or 10 mg zopiclone on two different study days separated by at least one week. Blood and OF were collected simultaneously at baseline and 9 times after intake of zopiclone on each study day. In addition an OF sample was collected 24–81 h after intake. Lunch was served between samples taken 2.5 and 3.5 h after intake. All samples were analysed for zopiclone, and the cut-off was 10 ng/ml in blood and 0.2 ng/ml in OF–buffer mixture. Results Zopiclone was detected in all OF samples during the study day. After 24–81 h, all subjects were also positive for zopiclone in OF, except from three subjects ingesting the 5 mg dose. In a single case zopiclone was detected in a baseline OF sample 14 days after intake on an earlier study day. Zopiclone was detected in both OF and blood in 231 OF/blood pairs, and a significant but weak correlation between OF and blood concentration was seen (R 2 of 0.30). The median (range) zopiclone OF/blood concentration ratio (ZOBCR) for all samples were 3.3 (0.8–18). The ZOBCR decreased when the OF volume increased. After 30 of 31 given doses of zopiclone, the ZOBCR was higher in samples collected before lunch than samples collected after lunch. Discussion Vast intra- and interindividual differences in ZOBCR were found, and the correlation between OF and blood concentration was less pronounced than reported in former studies. In accordance with earlier studies we found a negative correlation between ZOBCR and OF volume. The ZOBCR decreases in relation to recent intake of a meal, probably because stimulated saliva production causes “dilution” of saliva. OF zopiclone concentration appeared unsuitable for estimation of blood zopiclone concentration. Due to long detection time, analysis of zopiclone in OF might be useful to detect non-recent, previous intake.

About this research paper

What this paper is about

Purpose Little is known about the relationship between concentrations in oral fluid (OF) and blood for the widely prescribed hypnotic drug zopiclone . The purpose of this study was to investigate the usefulness of OF zopiclone concentrations to predict blood zopiclone concentrations in order to introduce OF testing as an alternative to more cumbersome blood testing. Methods 16 healthy young male volunteers received capsules of either 5 or 10 mg zopiclone on two different study days separated by at least one week. Blood and OF were collected simultaneously at baseline and 9 times after intake of zopiclone on each study day. In addition an OF sample was collected 24–81 h after intake. Lunch was served between samples taken 2.5 and 3.5 h after intake. All samples were analysed for zopiclone, and the cut-off was 10 ng/ml in blood and 0.2 ng/ml in OF–buffer mixture. Results Zopiclone was detected in all OF samples during the study day. After 24–81 h, all subjects were also positive for zopiclone in OF, except from three subjects ingesting the 5 mg dose. In a single case zopiclone was detected in a baseline OF sample 14 days after intake on an earlier study day. Zopiclone was detected in both OF and blood in 231 OF/blood pairs, and a significant but weak correlation between OF and blood concentration was seen (R 2 of 0.30). The median (range) zopiclone OF/blood concentration ratio (ZOBCR) for all samples were 3.3 (0.8–18). The ZOBCR decreased when the OF volume increased. After 30 of 31 given doses of zopiclone, the ZOBCR was higher in samples collected before lunch than samples collected after lunch. Discussion Vast intra- and interindividual differences in ZOBCR were found, and the correlation between OF and blood concentration was less pronounced than reported in former studies. In accordance with earlier studies we found a negative correlation between ZOBCR and OF volume. The ZOBCR decreases in relation to recent intake of a meal, probably because stimulated saliva production causes “dilution” of saliva. OF zopiclone concentration appeared unsuitable for estimation of blood zopiclone concentration. Due to long detection time, analysis of zopiclone in OF might be useful to detect non-recent, previous intake.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose Little is known about the relationship between concentrations in oral fluid (OF) and blood for the widely prescribed hypnotic drug zopiclone . The purpose of this study was to investigate the usefulness of OF zopiclone concentrations to predict blood zopiclone concentrations in order to introduce OF testing as an alternative to more cumbersome blood testing. Methods 16 healthy young male volunteers received capsules of either 5 or 10 mg zopiclone on two different study days separated by at least one week. Blood and OF were collected simultaneously at baseline and 9 times after intake of zopiclone on each study day. In addition an OF sample was collected 24–81 h after intake. Lunch was served between samples taken 2.5 and 3.5 h after intake. All samples were analysed for zopiclone, and the cut-off was 10 ng/ml in blood and 0.2 ng/ml in OF–buffer mixture. Results Zopiclone was detected in all OF samples during the study day. After 24–81 h, all subjects were also positive for zopiclone in OF, except from three subjects ingesting the 5 mg dose. In a single case zopiclone was detected in a baseline OF sample 14 days after intake on an earlier study day. Zopiclone was detected in both OF and blood in 231 OF/blood pairs, and a significant but weak correlation between OF and blood concentration was seen (R 2 of 0.30). The median (range) zopiclone OF/blood concentration ratio (ZOBCR) for all samples were 3.3 (0.8–18). The ZOBCR decreased when the OF volume increased. After 30 of 31 given doses of zopiclone, the ZOBCR was higher in samples collected before lunch than samples collected after lunch. Discussion Vast intra- and interindividual differences in ZOBCR were found, and the correlation between OF and blood concentration was less pronounced than reported in former studies. In accordance with earlier studies we found a negative correlation between ZOBCR and OF volume. The ZOBCR decreases in relation to recent intake of a meal, probably because stimulated saliva production causes “dilution” of saliva. OF zopiclone concentration appeared unsuitable for estimation of blood zopiclone concentration. Due to long detection time, analysis of zopiclone in OF might be useful to detect non-recent, previous intake.

Key concepts: Zopiclone, Hypnotic, Volunteer, Oral administration, Medicine, Chemistry, Anesthesia, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Zopiclone concentrations in oral fluid and blood after, administration of therapeutic doses of zopiclone — Research Paper | ScholarLens